» Authors » Dennis N Bourdette

Dennis N Bourdette

Explore the profile of Dennis N Bourdette including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 68
Citations 1055
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hartung D, Johnston K, McGregor J, Bourdette D
Neurol Clin Pract . 2022 Sep; 12(1):36-42. PMID: 36157618
Background And Objectives: To determine the association between Medicare Part D plan disease-modifying therapy (DMT) restrictiveness and adherence and outcomes among people with multiple sclerosis (MS). Methods: We used Medicare...
2.
Hartung D, Johnston K, McGregor J, Bourdette D
Int J MS Care . 2022 Apr; 24(2):90-97. PMID: 35462869
Background: Few studies have characterized the full spectrum of prescription drug use for individuals with multiple sclerosis (MS). The objective of this study was to describe patterns and expenditures for...
3.
Tran K, Harrod C, Bourdette D, Cohen D, Deodhar A, Hartung D
JAMA Intern Med . 2021 Dec; 182(2):206-217. PMID: 34902005
Importance: Repository corticotropin injection is an expensive medication that was approved in 1952 for the treatment of many inflammatory conditions. The clinical evidence supporting the use of repository corticotropin (hereinafter...
4.
Hartung D, Johnston K, Bourdette D, Chen R, Tseng C
Neurol Clin Pract . 2021 Sep; 11(4):298-303. PMID: 34484929
Objective: To determine whether closing the Part D coverage gap (donut hole) between 2010 and 2019 lowered patients' out-of-pocket costs for disease-modifying therapies (DMTs) for multiple sclerosis (MS). Methods: Using...
5.
Tagge I, Anderson V, Springer Jr C, Sammi M, Bourdette D, Spain R, et al.
J Neuroimaging . 2021 Aug; 31(6):1111-1118. PMID: 34355458
Background And Purpose: To compare transcapillary wall water exchange, a putative marker of cerebral metabolic health, in brain T white matter (WM) lesions and normal appearing white and gray matter...
6.
Knowles L, Hugos C, Cameron M, Haselkorn J, Bourdette D, Turner A
Am J Phys Med Rehabil . 2021 Aug; 101(4):405-409. PMID: 34347626
Fatigue is one of the most common and disabling symptoms of multiple sclerosis. A recent randomized controlled trial comparing a fatigue self-management program and a general multiple sclerosis education program...
7.
Tagge I, Kohama S, Sherman L, Bourdette D, Woltjer R, Wang P, et al.
J Neuroimaging . 2021 Apr; 31(3):480-492. PMID: 33930224
Background And Purpose: To describe MRI findings in Japanese macaque encephalomyelitis (JME) with emphasis on lesion characteristics, lesion evolution, normal-appearing brain tissue, and similarities to human demyelinating disease. Methods: MRI...
8.
Govindan A, Fitzpatrick K, Manoharan M, Tagge I, Kohama S, Ferguson B, et al.
Ann Clin Transl Neurol . 2021 Jan; 8(2):456-470. PMID: 33440071
Objective: To determine whether animals with Japanese macaque encephalomyelitis (JME), a spontaneous demyelinating disease similar to multiple sclerosis (MS), harbor myelin-specific T cells in their central nervous system (CNS) and...
9.
Hartung D, Johnston K, McGregor J, Bourdette D
Mult Scler Relat Disord . 2020 Oct; 46:102554. PMID: 33032059
Background: Medicare beneficiaries with multiple sclerosis (MS) often face high out-of-pocket (OOP) costs for disease-modifying therapies (DMTs). It is unclear how cost-sharing affects therapy initiation. Objectives: To estimate the effects...
10.
Anderson V, Tagge I, Li X, Quinn J, Kaye J, Bourdette D, et al.
J Neuroimaging . 2020 Jun; 30(5):658-665. PMID: 32558031
Background And Purpose: Transvascular water exchange plays a key role in the functional integrity of the blood-brain barrier (BBB). In white matter (WM), a variety of imaging modalities have demonstrated...